These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2102616)

  • 1. The structure and evolution of vertebrate fibrinogen: a comparison of the lamprey and mammalian proteins.
    Doolittle RF
    Adv Exp Med Biol; 1990; 281():25-37. PubMed ID: 2102616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid sequences of lamprey fibrinopeptides A and B and characterizations of the junctions split by lamprey and mammalian thrombins.
    Cottrell BA; Doolittle RF
    Biochim Biophys Acta; 1976 Dec; 453(2):426-38. PubMed ID: 999898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of vertebrate fibrinogen.
    Doolittle RF
    Fed Proc; 1976 Aug; 35(10):2145-9. PubMed ID: 947794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K; Terasawa F; Okumura N
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
    Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
    Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beta chain of chicken fibrinogen contains an atypical thrombin cleavage site.
    Weissbach L; Oddoux C; Procyk R; Grieninger G
    Biochemistry; 1991 Apr; 30(13):3290-4. PubMed ID: 2009266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DIFFERENCES IN THE CLOTTING OF LAMPREY FIBRINOGEN BY LAMPREY AND BOVINE THROMBINS.
    DOOLITTLE RF
    Biochem J; 1965 Mar; 94(3):735-41. PubMed ID: 14340065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete sequence of the lamprey fibrinogen alpha chain.
    Wang YZ; Patterson J; Gray JE; Yu C; Cottrell BA; Shimizu A; Graham D; Riley M; Doolittle RF
    Biochemistry; 1989 Dec; 28(25):9801-6. PubMed ID: 2611265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
    Murtaugh PA
    Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The minor form alpha' chain from lamprey fibrinogen is rapidly crosslinked during clotting.
    Shipwash E; Pan Y; Doolittle RF
    Proc Natl Acad Sci U S A; 1995 Feb; 92(4):968-72. PubMed ID: 7862675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid compositions of the subunit chains of lamprey fibrinogen. Evolutionary significance of some structural anomalies.
    Doolittle RF; Cottrell BA; Riley M
    Biochim Biophys Acta; 1976 Dec; 453(2):439-52. PubMed ID: 826275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structure of fragment double-D from cross-linked lamprey fibrin reveals isopeptide linkages across an unexpected D-D interface.
    Yang Z; Pandi L; Doolittle RF
    Biochemistry; 2002 Dec; 41(52):15610-7. PubMed ID: 12501189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
    Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel structure elucidation strategy for genetically abnormal fibrinogens with incomplete fibrinopeptide release as applied to fibrinogen Schwarzach.
    Henschen A; Kehl M; Deutsch E
    Hoppe Seylers Z Physiol Chem; 1983 Dec; 364(12):1747-51. PubMed ID: 6667926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
    Furlan M; Rupp C; Beck EA
    Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct measurement of a second fibrinogen alpha chain in lamprey blood plasma.
    Doolittle RF; Riley M; Pan Y
    Thromb Res; 1992 Dec; 68(6):489-93. PubMed ID: 1341060
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinogen and fibrin: biochemistry and pathophysiology.
    Budzynski AZ
    Crit Rev Oncol Hematol; 1986; 6(2):97-146. PubMed ID: 2878736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.